The FDA has approved Sanofi-Aventis’ Lantus SoloStar, a new prefilled, once-daily disposable insulin pen for Lantus (insulin glargine) for the treatment of ...
LANTUS(R) in the SoloSTAR(R) pen provides diabetes patients with an alternative to the traditional needle and syringe for insulin therapy. ...
In the news release, FDA Approves Lantus SoloStar(R) - A New Prefilled Disposable Insulin Pen For Use With LANTUS(R) In People With Type 1 And Type 2 ...
With LANTUS(R), the insulin is. day and night; therefore it has no pronounced peak. insulin for the control of high blood sugar. ...
The introduction of Lantus SoloStar(R) offers a convenient option for administering once-daily 24-hour LANTUS(R), the number one prescribed insulin in the ...
Sanofi-aventis announced today that the US Food and Drug Administration (FDA) approved Lantus SoloStar(R), a new prefilled disposable insulin pen for ...
This press release is an announcement submitted by Sanofi-Aventis on behalf of Lantus SoloStar®, and was not written by Diabetes Health. ...